ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Safety of RG2077 in Patients With Multiple Sclerosis

This study has been completed.
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00076934


Locations
United States, Massachusetts
Brigham and Women's Hospital/Harvard Medical School    
      Boston, Massachusetts, United States, 02115

Sponsors and Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Immune Tolerance Network

Investigators
Principal Investigator:     Samia J. Khoury, MD     Brigham and Women's Hospital    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers